spacer
home > white papers > Another Successful Visit Against the Odds - Medical Research Network (MRN) Limited
WHITE PAPERS
logo_Medical_Re.JPG

Medical Research Network (MRN) Limited

phone +44 (0) 1908 261 153
email Enquiries@themrn.co.uk
web http://www.themrn.co.uk/
email Talon House, Presley Way, Milton Keynes, Buckinghamshire, MK8 0ES

Another Successful Visit Against the Odds

Our dedicated team of nurses, couriers and project managers deliver, come rain or shine.

Making sure a Clinical Trial visit can go ahead in the home can be a complex process, and last month bad weather nearly stopped play on an important Home Trial Support visit. Thanks to the commitment and dedication from the entire team it went ahead against the odds.

The Challenge

The poor weather conditions meant that the Home Trial Support nurseís flight was delayed to Springfield MO, and the dose that was delivered to the patientís home was delayed from Florida to Dallas and then cancelled from Dallas to Springfield.

The Solution

The courier sent the dose to Arkansas and a driver drove the dose from Arkansas to Springfield; a two-hour trip during thunderstorms and poor weather warnings. The nurse managed to get to Springfield and was waiting in a local hotel for the dose to arrive. When the courier arrived at 00:30 they were able to hand the dose over to the nurse who then drove to the patientís home with the dose, in the storm, and was able to give the dose and finish the visit at 02:30am.

What incredible teamwork by both courier and nurse to ensure that the participant received the dose and the visit did not have to be rescheduled; both parties went above and beyond the call of duty. We are very appreciative of The MRN and the nurses that conduct the visits for the trial. It is because of their service that participant burden for the trial can be minimized. - Clinical Research Development Coordinator, Washington University School of Medicine in St. Louis.

While these situations arenít normal they do happen, and the MRN team are experienced in dealing with this and dedicated to ensuring all visits can happen safely and effectively for the patient, the nurse and the rest of the team. The nurses that we hire understand the importance of each visit and are dedicated to doing what is best for the patients at each visit.
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

TAGRISSOTM (osimertinib) DEMONSTRATED UNPRECEDENTED DISEASE-FREE SURVIVAL IN THE ADJUVANT TREATMENT OF STAGE IB-IIIA COMPLETELY RESECTED PATIENTS WITH EGFR MUTATION

Detailed results from the Phase III ADAURA trial showed AstraZenecaís Tagrisso (osimertinib) demonstrated a statistically significant and clinically meaningful improvement in disease-free survival (DFS) in the adjuvant treatment of patients with early-stage (IB, II and IIIA) epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after complete tumour resection with curative intent.
More info >>


White Papers

Antibody Internalization: Advanced Flow Cytometry and Live-Cell Analysis Give Rich Insights During Antibody Profiling

Sartorius Group

The natural characteristics of antibodies, such as high binding affinity, specificity to a wide variety of targets, and good stability, make them ideal therapeutic candidates for many diseases. Monoclonal antibodies (mAbs), in particular, deliver promising therapeutic results in several different disease areas, such as autoimmunity, oncology, and chronic inflammation. Researchersí abilities to improve the breadth of antibodies have been aided by innovative technologies for antibody discovery, for instance, through humanization of mouse antibodies and phage display. However, advanced antibody design techniques create the need for new screening methods so that lead candidates can be quickly and effectively identified as early in the development process as possible.
More info >>


Industry Events

Clinical Operations in Oncology Trials West Coast

17-18 November 2020, Hilton San Francisco Airport Bayfront

Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >>


©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement